Literature DB >> 7774141

Moraxella (Branhamella) catarrhalis bacteremia in children. A report of two patients and review of the literature.

G A Meyer1, T R Shope, N J Waecker, F H Lanningham.   

Abstract

We report two cases of Moraxella catarrhalis (M. catarrhalis) bacteremia in apparently healthy children. One patient had bilateral otitis media and the other had pharyngitis and sinusitis; both patients had uncomplicated clinical courses. A literature review revealed 22 reported cases of M. catarrhalis bacteremia in children, 14 (63%) of which occurred in patients who had no identified underlying condition. Eight (36%) cases were seen in children who were immunocompromised. Nine (40%) patients presented with either purpura, petechia, or a maculopapular rash. M. catarrhalis is well known as a respiratory pathogen, but it has not been recognized as a common cause of unsuspected bacteremia in children.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7774141     DOI: 10.1177/000992289503400305

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  10 in total

1.  Characterization of a novel porin protein from Moraxella catarrhalis and identification of an immunodominant surface loop.

Authors:  Donna M Easton; Adam Smith; Sara Gomez Gallego; A Ruth Foxwell; Allan W Cripps; Jennelle M Kyd
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

2.  Outer membrane protein B1, an iron-repressible protein conserved in the outer membrane of Moraxella (Branhamella) catarrhalis, binds human transferrin.

Authors:  A A Campagnari; T F Ducey; C A Rebmann
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

3.  Enhancement of clearance of bacteria from murine lungs by immunization with detoxified lipooligosaccharide from Moraxella catarrhalis conjugated to proteins.

Authors:  W G Hu; J Chen; J F Battey; X X Gu
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

4.  The transferrin binding protein B of Moraxella catarrhalis elicits bactericidal antibodies and is a potential vaccine antigen.

Authors:  L E Myers; Y P Yang; R P Du; Q Wang; R E Harkness; A B Schryvers; M H Klein; S M Loosmore
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

Review 5.  Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.

Authors:  K McGregor; B J Chang; B J Mee; T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

6.  Moraxella catarrhalis M35 is a general porin that is important for growth under nutrient-limiting conditions and in the nasopharynges of mice.

Authors:  Donna M Easton; Elke Maier; Roland Benz; A Ruth Foxwell; Allan W Cripps; Jennelle M Kyd
Journal:  J Bacteriol       Date:  2008-10-17       Impact factor: 3.490

7.  Cloning and expression of the Moraxella catarrhalis lactoferrin receptor genes.

Authors:  R P Du; Q Wang; Y P Yang; A B Schryvers; P Chong; M H Klein; S M Loosmore
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

8.  Influence of Moraxella sp. colonization on the kidney proteome of farmed gilthead sea breams (Sparus aurata, L.).

Authors:  Maria Filippa Addis; Roberto Cappuccinelli; Vittorio Tedde; Daniela Pagnozzi; Iolanda Viale; Mauro Meloni; Fulvio Salati; Tonina Roggio; Sergio Uzzau
Journal:  Proteome Sci       Date:  2010-10-12       Impact factor: 2.480

9.  Clinical characteristics of the patients with bacteremia due to Moraxella catarrhalis in children: a case-control study.

Authors:  Takanori Funaki; Eisuke Inoue; Isao Miyairi
Journal:  BMC Infect Dis       Date:  2016-02-09       Impact factor: 3.090

10.  Mucosal immunization with the Moraxella Catarrhalis porin m35 induces enhanced bacterial clearance from the lung: a possible role for opsonophagocytosis.

Authors:  Donna M Easton; Allan W Cripps; A Ruth Foxwell; Jennelle M Kyd
Journal:  Front Immunol       Date:  2011-05-16       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.